IL197362A0 - Method for reducing or alleviating inflammation in the digestive tract - Google Patents
Method for reducing or alleviating inflammation in the digestive tractInfo
- Publication number
- IL197362A0 IL197362A0 IL197362A IL19736209A IL197362A0 IL 197362 A0 IL197362 A0 IL 197362A0 IL 197362 A IL197362 A IL 197362A IL 19736209 A IL19736209 A IL 19736209A IL 197362 A0 IL197362 A0 IL 197362A0
- Authority
- IL
- Israel
- Prior art keywords
- reducing
- digestive tract
- alleviating inflammation
- subject
- alleviating
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 102000053723 Angiotensin-converting enzyme 2 Human genes 0.000 abstract 1
- 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 abstract 1
- 208000037273 Pathologic Processes Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000009054 pathological process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82507506P | 2006-09-08 | 2006-09-08 | |
| US82780706P | 2006-10-02 | 2006-10-02 | |
| PCT/US2007/077857 WO2008031014A1 (en) | 2006-09-08 | 2007-09-07 | Method for reducing or alleviating inflammation in the digestive tract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL197362A0 true IL197362A0 (en) | 2009-12-24 |
Family
ID=38670723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL197362A IL197362A0 (en) | 2006-09-08 | 2009-03-03 | Method for reducing or alleviating inflammation in the digestive tract |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20080234345A1 (https=) |
| EP (1) | EP2059234B1 (https=) |
| JP (1) | JP2010502736A (https=) |
| CN (1) | CN101568331A (https=) |
| AT (1) | ATE531362T1 (https=) |
| AU (1) | AU2007292247A1 (https=) |
| CA (1) | CA2662535A1 (https=) |
| DK (1) | DK2059234T3 (https=) |
| ES (1) | ES2376493T3 (https=) |
| IL (1) | IL197362A0 (https=) |
| WO (1) | WO2008031014A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2095819A1 (en) * | 2008-02-28 | 2009-09-02 | Maastricht University | N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors |
| JP2011513491A (ja) * | 2008-03-10 | 2011-04-28 | オレ・ファーマシューティカルズ・インコーポレーテッド | 近位消化管の障害の治療 |
| WO2010093804A1 (en) * | 2009-02-12 | 2010-08-19 | Ore Pharmaceuticals, Inc. | Ace2 inhibitors for reducing gastrointestinal adverse effects of cytotoxic agents |
| EP2543388A4 (en) * | 2010-03-04 | 2013-11-27 | Dainippon Sumitomo Pharma Co | MEDICINAL PRODUCT FOR INFLAMMATORY ENDURANCE |
| PT2544679T (pt) | 2010-03-12 | 2019-07-11 | Omeros Corp | Inibidores de pde-10 e composições e métodos relacionados |
| NZ716494A (en) | 2014-04-28 | 2017-07-28 | Omeros Corp | Processes and intermediates for the preparation of a pde10 inhibitor |
| NZ630803A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Optically active pde10 inhibitor |
| MA41271A (fr) * | 2014-12-26 | 2017-10-31 | Celgene Alpine Invest Company Ii Llc | Méthodes d'utilisation d'oligonucléotides antisens ciblant smad7 |
| US9879002B2 (en) | 2015-04-24 | 2018-01-30 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
| US9920045B2 (en) | 2015-11-04 | 2018-03-20 | Omeros Corporation | Solid state forms of a PDE10 inhibitor |
| GB202116266D0 (en) * | 2021-11-11 | 2021-12-29 | Bicycletx Ltd | Novel use |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6194556B1 (en) * | 1997-12-11 | 2001-02-27 | Millennium Pharmaceuticals, Inc. | Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor |
| CN1377259A (zh) * | 1999-04-30 | 2002-10-30 | 千年药品公司 | 抑制ace－2的化合物及其使用方法 |
| US7045532B2 (en) * | 1999-04-30 | 2006-05-16 | Millennium Pharmaceuticals, Inc. | ACE-2 modulating compounds and methods of use thereof |
| WO2002098448A1 (en) | 2001-06-04 | 2002-12-12 | Human Genome Sciences, Inc. | Methods and compositions for modulating ace-2 activity |
| GB0203061D0 (en) | 2002-02-08 | 2002-03-27 | Novartis Ag | Organic compounds |
| BR0314713A (pt) * | 2002-09-24 | 2005-07-26 | Combinatorx Inc | Processos e reagentes para o tratamento de doenças e distúrbios associados com nìveis aumentados de citocinas pró-inflamatórias |
| JP2006517969A (ja) * | 2003-02-14 | 2006-08-03 | コンビナトアールエックス インコーポレーティッド | 免疫炎症性障害の治療のための組み合わせ療法 |
| US20050203168A1 (en) * | 2004-03-11 | 2005-09-15 | The Regents Of The University Of Michigan | Angiotensin converting enzyme inhibitor use for treatment and prevention of gastrointestinal disorders |
| WO2008031013A1 (en) * | 2006-09-08 | 2008-03-13 | Gene Logic Inc. | Method for treating inflammatory diseases of the digestive tract |
-
2007
- 2007-09-07 US US11/851,694 patent/US20080234345A1/en not_active Abandoned
- 2007-09-07 CN CNA2007800394181A patent/CN101568331A/zh active Pending
- 2007-09-07 AU AU2007292247A patent/AU2007292247A1/en not_active Abandoned
- 2007-09-07 WO PCT/US2007/077857 patent/WO2008031014A1/en not_active Ceased
- 2007-09-07 DK DK07814746.9T patent/DK2059234T3/da active
- 2007-09-07 CA CA002662535A patent/CA2662535A1/en not_active Abandoned
- 2007-09-07 JP JP2009527579A patent/JP2010502736A/ja active Pending
- 2007-09-07 ES ES07814746T patent/ES2376493T3/es active Active
- 2007-09-07 AT AT07814746T patent/ATE531362T1/de active
- 2007-09-07 EP EP07814746A patent/EP2059234B1/en not_active Not-in-force
-
2009
- 2009-03-03 IL IL197362A patent/IL197362A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2376493T3 (es) | 2012-03-14 |
| JP2010502736A (ja) | 2010-01-28 |
| ATE531362T1 (de) | 2011-11-15 |
| AU2007292247A1 (en) | 2008-03-13 |
| EP2059234A1 (en) | 2009-05-20 |
| WO2008031014A1 (en) | 2008-03-13 |
| AU2007292247A2 (en) | 2009-03-26 |
| DK2059234T3 (da) | 2011-11-28 |
| CA2662535A1 (en) | 2008-03-13 |
| CN101568331A (zh) | 2009-10-28 |
| EP2059234B1 (en) | 2011-11-02 |
| US20080234345A1 (en) | 2008-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL197362A0 (en) | Method for reducing or alleviating inflammation in the digestive tract | |
| WO2009055783A3 (en) | Anti-pcsk9 and methods for treating lipid and cholesterol disorders | |
| IN2012DN02661A (https=) | ||
| MX2009011749A (es) | Compuestos triciclicos como inhibidores de metaloproteinasa matricial. | |
| EA031157B9 (ru) | Вводимая перорально кортикостероидная композиция | |
| IL197350A0 (en) | Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof | |
| IL186749A0 (en) | Dihydrothienopyrimidines for the treatment of inflammatory diseases | |
| PL2056807T3 (pl) | Leczenie chorób zakaźnych | |
| MX337634B (es) | Anillos intravaginales monoliticos que comprenden progesterona y metodos de manufactura y uso de los mismos. | |
| UA102097C2 (ru) | Способ лечения воспалительного заболевания с применением соединения, которое нейтрализует gm-csf, и соединения, которое нейтрализует il-17 | |
| EP2671891A3 (en) | Ang-2 inhibition to treat multiple sclerosis | |
| NZ594365A (en) | Dual targeting of miR-208a or miR-208b and miR-499 in the treatment of cardiac disorders or musculoskeletal disorders | |
| WO2008139263A3 (en) | Methods for slowing the progression of multiple sclerosis | |
| WO2006132959A3 (en) | Inhibition of thrombin generation | |
| CA2837895C (en) | Methods of treating or preventing neurological diseases | |
| WO2007084651A3 (en) | Methods and kits to treat chronic inflammatory immune diseases | |
| WO2007147868A3 (en) | Prevention of muscle atrophy | |
| WO2007097980A3 (en) | Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy | |
| WO2009155070A3 (en) | Compositions and methods for treatment of inflammation and hyperkeratotic lesions | |
| WO2007103727A3 (en) | Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kb | |
| MX2010002032A (es) | Uso de flibanserina para el tratamiento de sintomas vasomotores. | |
| WO2008042892A3 (en) | Fatty acid amide hydrolase inhibitors for energy metabolism disorders | |
| WO2011038924A3 (en) | Proteasome inhibitors for treating cancer | |
| MX2010013790A (es) | Composiciones y metodos para tratar inflamacion de corneas. | |
| WO2011133479A3 (en) | Combination therapy with a proteasome inhibitor and a gallium complex |